Cytek Biosciences (CTKB) Revenue & Revenue Breakdown
Cytek Biosciences Revenue Highlights
Latest Revenue (Y)
$193.01M
Latest Revenue (Q)
$46.62M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Cytek Biosciences Revenue by Period
Cytek Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $193.01M | 17.67% |
| 2022-12-31 | $164.04M | 28.20% |
| 2021-12-31 | $127.95M | 37.82% |
| 2020-12-31 | $92.84M | 60.39% |
| 2019-12-31 | $57.88M | - |
Cytek Biosciences generated $193.01M in revenue during NA 2023, up 17.67% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Cytek Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $46.62M | 3.92% |
| 2024-03-31 | $44.86M | -22.96% |
| 2023-12-31 | $58.23M | 21.32% |
| 2023-09-30 | $48.00M | -3.41% |
| 2023-06-30 | $49.69M | 33.99% |
| 2023-03-31 | $37.09M | -23.27% |
| 2022-12-31 | $48.34M | 19.42% |
| 2022-09-30 | $40.48M | 0.79% |
| 2022-06-30 | $40.16M | 14.53% |
| 2022-03-31 | $35.06M | -9.85% |
| 2021-12-31 | $38.89M | 13.14% |
| 2021-09-30 | $34.38M | 13.05% |
| 2021-06-30 | $30.41M | 25.28% |
| 2021-03-31 | $24.27M | -20.73% |
| 2020-12-31 | $30.62M | 22.01% |
| 2020-09-30 | $25.10M | 31.15% |
| 2020-06-30 | $19.14M | 6.38% |
| 2020-03-31 | $17.99M | - |
Cytek Biosciences generated $46.62M in revenue during Q2 2024, up 3.92% compared to the previous quarter, and up 125.69% compared to the same period a year ago.
Cytek Biosciences Revenue Breakdown
Cytek Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Product | $156.72M | $148.60M | $119.52M |
| Service | $36.49M | $15.44M | $8.43M |
Cytek Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (81.11%), and Service (18.89%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $36.87M | - | $37.00M | $9.24M | $5.92M | $4.70M | $4.09M | $3.07M | $3.58M | $2.94M | $2.19M | $1.73M |
| Product | $34.12M | $46.65M | $38.44M | $40.45M | $31.17M | $43.64M | $36.39M | $37.09M | $31.48M | $35.95M | $32.19M | $28.68M |
Cytek Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Service (51.93%), and Product (48.07%).
Cytek Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| EMEA | $53.18M | $43.96M | $36.97M |
| Asia Pacific | $31.60M | $22.52M | $16.08M |
| UNITED STATES | $102.08M | $94.59M | $72.72M |
| Other | $6.15M | $2.96M | $2.18M |
Cytek Biosciences's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (52.89%), EMEA (27.55%), Asia Pacific (16.37%), and Other (3.19%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $21.36M | $24.02M | $26.79M | $31.44M | $19.84M | $26.70M | $22.81M | $24.76M | $20.32M | $18.14M | $23.98M | $17.25M |
| EMEA | $15.13M | $21.14M | $12.92M | $9.08M | $10.03M | $16.14M | $10.30M | $8.84M | $8.68M | $13.48M | $6.18M | - |
| Asia Pacific | $6.35M | $11.57M | $6.76M | $7.05M | $6.22M | $4.22M | $7.15M | $6.14M | $5.01M | $6.63M | $2.80M | $3.39M |
| Other | $2.02M | $1.51M | $1.53M | $2.12M | $996.00K | $1.29M | $212.00K | $418.00K | $1.04M | $633.00K | $1.42M | $111.00K |
| E M E A | - | - | - | - | - | - | - | - | - | - | - | $9.66M |
Cytek Biosciences's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (47.61%), EMEA (33.72%), Asia Pacific (14.16%), and Other (4.51%).
Cytek Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| INGN | Inogen | $315.66M | $88.77M |
| CTKB | Cytek Biosciences | $193.01M | $46.62M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| RXST | RxSight | $89.08M | $45.52M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| VAPO | Vapotherm | $68.67M | $16.88M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| APYX | Apyx Medical | $52.35M | $12.15M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| OSA | ProSomnus | $27.65M | $7.46M |
| TLIS | Talis Biomedical | $412.00K | - |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
CTKB Revenue FAQ
What is Cytek Biosciences’s yearly revenue?
Cytek Biosciences's yearly revenue for 2023 was $193.02M, representing an increase of 17.67% compared to 2022. The company's yearly revenue for 2022 was $164.04M, representing an increase of 28.20% compared to 2021. CTKB's yearly revenue for 2021 was $127.95M, representing an increase of 37.82% compared to 2020.
What is Cytek Biosciences’s quarterly revenue?
Cytek Biosciences's quarterly revenue for Q2 2024 was $46.62M, a 3.92% increase from the previous quarter (Q1 2024), and a -6.19% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $44.86M, a -22.96% decrease from the previous quarter (Q4 2023), and a 20.96% increase year-over-year (Q1 2023). CTKB's quarterly revenue for Q4 2023 was $58.23M, a 21.32% increase from the previous quarter (Q3 2023), and a 20.48% increase year-over-year (Q4 2022).
What is Cytek Biosciences’s revenue growth rate?
Cytek Biosciences's revenue growth rate for the last 3 years (2021-2023) was 50.85%, and for the last 5 years (2019-2023) was 233.46%.
What are Cytek Biosciences’s revenue streams?
Cytek Biosciences's revenue streams in c 23 are Product, and Service. Product generated $156.72M in revenue, accounting 81.11% of the company's total revenue, up 5.46% year-over-year. Service generated $36.49M in revenue, accounting 18.89% of the company's total revenue, up 136.40% year-over-year.
What is Cytek Biosciences’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Cytek Biosciences was Product. This segment made a revenue of $156.72M, representing 81.11% of the company's total revenue.